IDEAYA Biosciences, Inc. — Investor Relations & Filings
IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 | 2022-03-03 | English | |
| FORM 4 | 2022-03-03 | English | |
| FORM 4 | 2022-03-03 | English | |
| SCHEDULE 13G | 2022-02-18 | English | |
| Major Shareholding Notification 2022 | 2022-02-14 | English | |
| Major Shareholding Notification 2022 | 2022-02-14 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
9 filings
| |||||
| 12964656 | FORM 4 | 2022-03-03 | English | ||
| 12964658 | FORM 4 | 2022-03-03 | English | ||
| 12964659 | FORM 4 | 2022-03-03 | English | ||
| 12964660 | SCHEDULE 13G | 2022-02-18 | English | ||
| 12964661 | Major Shareholding Notification 2022 | 2022-02-14 | English | ||
| 12964664 | Major Shareholding Notification 2022 | 2022-02-14 | English | ||
| 12964665 | IDEAYA BIOSCIENCES, INC. | 2022-02-14 | English | ||
| 12964666 | AMENDMENT NO. 5 TO THE SCHEDULE 13G | 2022-02-12 | English | ||
| 12964668 | Major Shareholding Notification 2022 | 2022-02-04 | English | ||
|
2021
6 filings
| |||||
| 12964669 | Major Shareholding Notification 2021 | 2021-12-01 | English | ||
| 12964670 | 10-Q | 2021-11-15 | English | ||
| 12964671 | 8-K | 2021-11-15 | English | ||
| 12964672 | FORM 4 | 2021-10-27 | English | ||
| 12964673 | FORM 3 | 2021-10-27 | English | ||
| 12964674 | FORM 4 | 2021-10-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IDEAYA Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IDEAYA Biosciences, Inc. (id: 31547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.